Maurizio Bifulco
Maurizio Bifulco
Verified email at unisa.it
TitleCited byYear
The endocannabinoid system and its therapeutic exploitation
V Di Marzo, M Bifulco, L De Petrocellis
Nature reviews Drug discovery 3 (9), 771, 2004
10382004
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
L De Petrocellis, D Melck, A Palmisano, T Bisogno, C Laezza, M Bifulco, ...
Proceedings of the National Academy of Sciences 95 (14), 8375-8380, 1998
4211998
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
A Ligresti, AS Moriello, K Starowicz, I Matias, S Pisanti, L De Petrocellis, ...
Journal of Pharmacology and Experimental Therapeutics 318 (3), 1375-1387, 2006
3872006
Pharmacological actions of statins: a critical appraisal in the management of cancer
P Gazzerro, MC Proto, G Gangemi, AM Malfitano, E Ciaglia, S Pisanti, ...
Pharmacological reviews 64 (1), 102-146, 2012
3162012
Role of the small GTPase Rab7 in the late endocytic pathway
R Vitelli, M Santillo, D Lattero, M Chiariello, M Bifulco, CB Bruni, C Bucci
Journal of Biological Chemistry 272 (7), 4391-4397, 1997
2961997
Possible endocannabinoid control of colorectal cancer growth
A Ligresti, T Bisogno, I Matias, L De Petrocellis, MG Cascio, V Cosenza, ...
Gastroenterology 125 (3), 677-687, 2003
2692003
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation
D Melck, L De Petrocellis, P Orlando, T Bisogno, C Laezza, M Bifulco, ...
Endocrinology 141 (1), 118-126, 2000
2602000
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors
D Melck, T Bisogno, L De Petrocellis, H Chuang, D Julius, M Bifulco, ...
Biochemical and biophysical research communications 262 (1), 275-284, 1999
2071999
Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis
G Portella, C Laezza, P Laccetti, L De Petrocellis, V Di Marzo, M Bifulco
The FASEB Journal 17 (12), 1771-1773, 2003
1912003
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells
V Di MARZO, D MELCK, P ORLANDO, T BISOGNO, O ZAGOORY, ...
Biochemical Journal 358 (1), 249-255, 2001
1862001
Targeting the endocannabinoid system in cancer therapy: a call for further research
M Bifulco, V Di Marzo
Nature medicine 8 (6), 547, 2002
1782002
Cannabinoids and cancer: pros and cons of an antitumour strategy
M Bifulco, C Laezza, S Pisanti, P Gazzerro
British journal of pharmacology 148 (2), 123-135, 2006
1532006
2′, 3′-Cyclic nucleotide 3′-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin
M Bifulco, C Laezza, S Stingo, J Wolff
Proceedings of the National Academy of Sciences 99 (4), 1807-1812, 2002
1532002
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth
M Bifulco, C Laezza, G Portella, M Vitale, P Orlando, L De Petrocellis, ...
The FASEB Journal 15 (14), 2745-2747, 2001
1532001
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
M Donadelli, I Dando, T Zaniboni, C Costanzo, E Dalla Pozza, MT Scupoli, ...
Cell death & disease 2 (4), e152, 2011
1522011
Anandamide inhibits adhesion and migration of breast cancer cells
C Grimaldi, S Pisanti, C Laezza, AM Malfitano, A Santoro, M Vitale, ...
Experimental cell research 312 (4), 363-373, 2006
1522006
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation
M Bifulco, C Laezza, M Valenti, A Ligresti, G Portella, V Di Marzo
The FASEB journal 18 (13), 1606-1608, 2004
1432004
The endocannabinoid signaling system in cancer
S Pisanti, P Picardi, A D’Alessandro, C Laezza, M Bifulco
Trends in pharmacological sciences 34 (5), 273-282, 2013
1252013
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism
D Sarnataro, S Pisanti, A Santoro, P Gazzerro, AM Malfitano, C Laezza, ...
Molecular pharmacology 70 (4), 1298-1306, 2006
1132006
Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling
G Cuda, R Paterṇ, R Ceravolo, M Candigliota, N Perrotti, F Perticone, ...
Circulation 105 (8), 968-974, 2002
1032002
The system can't perform the operation now. Try again later.
Articles 1–20